Flow diagram of study design. Fifty-nine New Zealand White rabbits had focal femoral artery atherosclerosis induced by air desiccation endothelial injury followed by a high-cholesterol diet. After balloon angioplasty, arteries were assigned to treatment with intramural heparin via a porous balloon catheter or to no intramural treatment. Subsequently, rabbits were assigned to treatment with subcutaneous heparin for 28 days or to no further heparin treatment. The four resulting treatment groups are shown. Rabbits were killed at 28 days after angioplasty for angiographic, histological, and morphometric analysis ofsuccessfully angioplastied femoral arteries. % 28 Days X AngFography Histology Morphometrics and proliferation appear to be specifically inhibited by heparin, whereas endothelial regeneration is not.12 Both anticoagulant and nonanticoagulant heparin fragments have been developed that inhibit the proliferation of vascular smooth muscle cells in vivo and in vitro. 13 There is increasing interest in "site-specific" or "direct" delivery of antiproliferative agents into the arterial wall. Edelman and associates14 reported the inhibition of smooth muscle cell proliferation after vascular injury by surgical placement of a heparin-impregnated polymer matrix in the periadventitial tissues of rat carotid arteries. This route of administration was more effective than either intravenous or subcutaneous delivery of heparin. The recent development of a catheter-based porous balloon has permitted the application of "site-specificity" to percutaneous techniques. Wolinsky and associates15,16 have documented the feasibility of this concept using heparin in the normal canine artery and in postmortem specimens. The present angiographic and histopathological study investigates the effects of chronic subcutaneous (systemic) and/or intramural (site-specific) delivery of heparin on restenosis after angioplasty of atherosclerotic femoral arteries in rabbits.
Methods
The experimental design is summarized in Figure 1 . Details of this experimental model have been published previously. [17] [18] [19] Induction of Focal Atherosclerosis Fifty-nine male New Zealand White rabbits (weight, 4.0±0.4 kg) were anesthetized with ketamine (50 mg/kg i.m.) and xylocaine (5 mg/kg i.m.). Femoral artery segments (1-2 cm in length) were exposed bilaterally 1 cm below the inguinal ligament and secured between airtight ligatures. Endothelial damage was induced by air desiccation with nitrogen gas. Beginning the next day, animals were fed a diet consisting of 2% cholesterol and 6% peanut oil for 1 month. We have previously shown that cholesterol levels increase approximately 20-to 25- [1,000 units/cm3 with activity of 170 units/mg], Polysciences, Inc., Warrington, Pa.) was delivered into the angioplastied segment of one femoral artery by a 2.5-mm porous balloon. The contralateral angioplastied femoral artery was not treated with the porous balloon and served as a sham-operated control. Five minutes after repeat angiography, the animal was killed, and both femoral arteries were harvested. The arteries were dissected longitudinally and sectioned transversely in the angioplastied region. Optical images were taken from different planes (z resolution, 0.9 ttm) to detect the amount of heparin fluorescence in the plaque, media, and adventitia with a Bio-Rad MRC-600 confocal microscope (Bio-Rad, Cambridge, Mass.).20 Because the confocal microscope collects signal only from the focal plane (while discarding "blurred" signal), fluorescence in individual layers of the arterial wall can be discriminated.
Killing ofAnimals and Pressure Perfusion
With the angiographic catheter positioned above the aortoiliac bifurcation, the distal arterial tree was perfused with 10% buffered formaldehyde (100 ml for 15 minutes, 100 mm Hg, 22°C). At the start of perfusion, animals were administered an overdose of sodium pentobarbital. A 4-5-cm segment of each femoral artery was excised, and the proximal and distal ends were marked with silk sutures. The specimens were preserved in 10% formaldehyde for light microscopy.
Quantitative Angiography
All quantitative angiographic measurements were performed by blinded analysis using a computer-assisted system described previously. 19, 21 This blinded analysis was repeated after 3 months. The 35-mm cine frame selected for analysis was mounted in a film holder and projected through a modified Tagarno 35 CX projector (Tagarno A/S, Horsens, Denmark) into a companion videocamera. The video signal was then digitized and stored in a frame grabber board (model DT2861, Data Translation, Inc., Marlboro, Mass.). Analysis was performed using IMAGE-PRO image processing software (Media Cybernetics, Inc., Silver Spring, Md.) in association with an Everex personal computer (model C, System 1700, Fremont, Calif.). Before analysis of the baseline angiogram, the system was calibrated by use of a grid with 1-cm markings placed at the level of the femoral arteries. The minimum luminal diameters (in millimeters) were determined at the sites of focal femoral artery stenosis, of segments proximal and distal to the stenosis, and of the in vivo balloon dimension by placement of a computergenerated line perpendicular to the long axis of the artery. By a prospective definition,19 the site examined for restenosis was the point of maximal narrowing on the preangioplasty angiogram even if this was not the most severely narrowed site at subsequent time points. Templates were drawn of the preangioplasty angiograms to ensure that the quantitative analyses repeated at 28 days were performed on these same arterial sites. The percent stenosis was defined as the ratio of the minimal luminal diameter to the average of the adjacent segments and was expressed as a decimal fraction. In addition, angiographic measurements were made at 4-mm intervals along the site of balloon angioplasty to evaluate the luminal diameter change over the whole angioplastied segment and to mimic the 4- 
Partial Thromboplastin Time
All animals received an intra-arterial bolus of heparin immediately before angioplasty. This resulted in prolongation of the partial thromboplastin time from 109+29 seconds at baseline to >200 seconds at the end of the procedure (p<0.0001). The partial thromboplastin time of animals treated chronically with subcutaneous heparin remained prolonged at the midpoint between subcutaneous doses (6 hours after injection)
This confirmed that an anticoagulant dose of heparin was used.
Intramural Delivery of Heparin by Porous Balloon Catheter
To confirm intramural delivery in this atherosclerotic rabbit model, fluoresceinated heparin was delivered by the porous balloon after angioplasty in one animal. By confocal microscopy, the fluorescein was detected to have reached the atherosclerotic plaque and underlying media with localization in the nuclei of the medial and neointimal cells (Figure 2 ). In the contralateral artery not treated with the porous balloon, minimal background fluorescence was seen. Angiography
The results of angiography are summarized in Table  1 . The individual minimal luminal diameters in the four treatment groups measured before and after balloon angioplasty, after treatment with the porous balloon, and at 28 days after angioplasty are depicted in Figure  3 . There was a significant increase in minimal luminal diameter from before to immediately after angioplasty among arteries with successful angioplasty (>10% initial improvement in minimal luminal diameter) (p<O.OOl) and a significant reduction in minimal luminal diameter at 42±23%; p=NS) ( Table 2 ). The cross-sectional area narrowing by plaque for individual arteries is summarized in Figure 7 . The quadrant method of analysis similarly showed no significant differences in luminal narrowing by plaque among groups. The absolute lumen areas, plaque areas, and plaque/media ratios were not significantly different among the four treatment groups (Table 2) . Vascular injury. There were no significant differences in the overall frequency or severity of plaque tears between the treatment groups and no differences in frequency of mural hemorrhage, severe medial necrosis, or extensive inflammatory cell infiltration ( Figure 8 ). Comparisons between the four treatment groups showed a significantly lower percentage of foam cells in arteries treated with subcutaneous heparin. Arteries treated with chronic subcutaneous heparin had a lower percentage of foam cells (2+4%) than either controls (10+22%,p<0.05) or arteries treated with intramural delivery of heparin only (11+20%, p<0.05) but had a similar percentage to those treated with intramural and subcutaneous heparin (4±10%, p=0.35). Calcific deposits were absent.
Discussion
We conclude that although heparin can be effectively delivered into an atherosclerotic plaque, this "sitespecific" therapy does not reduce restenosis in our model. Chronic administration of subcutaneous heparin for 28 days after angioplasty resulted in modest reduction in angiographic restenosis, but this treatment did not improve luminal diameter compared with preangioplasty, and quantitative histopathology showed no reduction in luminal cross-sectional area narrowing by plaque or in plaque area. Because previous investigators had shown more marked reductions in plaque area with heparin treatment in other models,14 our data emphasize that heparin's effect on restenosis may depend on the model studied, the presence or absence of preexisting atherosclerotic plaque, and on the extent of injury.
Although previous studies have suggested that "sitespecific" therapy with heparin might reduce smooth muscle cell migration and proliferation after vascular injury, in our study quantitative angiography showed no reduction in restenosis after direct intramural delivery of heparin via a porous balloon catheter. Quantitative histopathological analysis by computerized planimetry also showed no effect on luminal cross-sectional area narrowing by plaque at 28 days. There are several potential explanations for the lack of benefit of intramural heparin administration in this model compared with previous reports. Adventitial heparin delivery (anticoagulant or nonanticoagulant) via surgically placed heparin-impregnated polymers has been shown to reduce intimal hyperplasia after balloon injury of normal rat carotid artery. It is known, however, that the arterial response to injury of an abnormal artery (second injury) can be significantly different, with thrombosis playing a more important role. 23 Additionally, atherosclerotic models may more closely reproduce the varied cell types present in human atherosclerotic plaques at the time of balloon angioplasty. We investigated the use of a clinically relevant method of delivering heparin into the arterial wall by use of a catheter-based system. It is possible, however, that the 5-atm porous balloon inflation used for the local administration of heparin resulted in additional arterial injury not apparent by angiography or light microscopy. We cannot exclude that increased arterial injury resulting from this system masked any relative benefit resulting from the local administration of heparin. The present studies using fluoresceinated heparin confirmed previous reports15"16 that the porous balloon can reliably deliver heparin into the arterial wall. Although the final concentration of heparin in the wall was not directly measured in this chronic animal model, the maximal dose of heparin was used that did not result in excessive systemic anticoagulation. It is of interest that fluoresceinated heparin was seen throughout the atherosclerotic plaque and underlying media with evidence of localization of heparin to the nuclei of medial and neointimal cells (Figure 2 ). There is uncertainty regarding the permeability of normal smooth muscle cells to heparin.20 In this study, light microscopy at 28 days suggested extensive medial necrosis associated with balloon angioplasty in all treatment groups (Table 2 ). It is possible that penetration of fluoresceinated heparin into smooth muscle cells resulted from cellular damage after balloon angioplasty. The localization of heparin to the cellular nucleus is thought to occur by interaction with a chromatin-associated inner histone. 24 We hypothesized that heparin, possibly because of its antithrombin, antithrombotic, and antiproliferative effects, would reduce restenosis after balloon angioplasty. Thrombin activity is known to be elevated for up to 10 days after vascular injury. of thrombin. In our study, quantitative computer-assisted angiography did show less restenosis in arteries receiving chronic subcutaneous heparin compared with controls. However, none of the groups had significant improvement in luminal diameters at 28 days compared with preangioplasty. Restenosis in humans is best defined as the change in angiographic minimal luminal diameter from immediately after balloon angioplasty to time of follow-up.29 Therefore, we used this prospective definition as the primary angiographic endpoint in this and previous studies. To account for apparent differences in the angiographic and histological results in this study, we mimicked histological sectioning by analyzing each 28-day angiogram at 4-mm intervals along the arterial segment undergoing balloon angioplasty. With this technique, no significant differences were seen among the four treatment groups. Consistent with this finding, morphometric analysis of histological sections taken at 4-mm intervals showed similar percent luminal cross-sectional narrowing by atherosclerotic plaque among the four treatment groups when examined at the single 28-day time point. Furthermore, no significant differences were seen in plaque or media area or in the plaque-to-media ratio. As was previously seen when the more potent thrombin inhibitor recombinant desulphatohirudin was used, the foam cell content of plaque was reduced by chronic subcutaneous heparin. However, the inhibition of plaque growth with recombinant desulphatohirudin documented histopathologically was not seen with heparin at the dose used, possibly because heparin is a less potent antithrombin agent.
Limitations of the Study
Optimal heparin dosing to be used in balloon angioplasty in humans or animals is unknown. Because an intravenous heparin bolus was necessary to avoid acute catheter-related thrombosis, we cannot exclude the possibility that the heparin bolus used in controls had some effect on late restenosis. Although the subcutaneous dose used here resulted in "therapeutic anticoagulation" (prolongation of the activated partial thromboplastin time to >1.5 times control between doses), it is known that even very high doses of heparin do not completely inhibit the mural thrombosis associated with deep arterial injury. 30 We did not specifically measure the heparin levels achieved locally in the atherosclerotic plaque after chronic subcutaneous administration of heparin, but instead decided to investigate the use of clinically applicable doses of subcutaneous heparin. Dosing of intramural heparin by use of the porous balloon was limited by the systemic anticoagulation resulting from release of heparin intra-arterially during low-pressure balloon inflation. We decided that arteries treated with the porous balloon would receive one additional (low-pressure) balloon inflation (compared with controls), because this would be a clinically relevant method. No additional arterial injury was observed angiographically or histologically by this technique. Previous investigators1516 have documented that heparin can be reliably delivered into both normal and atherosclerotic arterial wall by the porous balloon. Our single experiment using fluoresceinated heparin was done to document heparin delivery after balloon angioplasty in our atherosclerotic model.
No animal model of balloon angioplasty exactly reproduces the experience in humans. Human restenosis trials, however, are enormously expensive and fail to answer many mechanistic questions regarding vascular injury and healing. Animal models allow for the systematic comparison of angiographic and histological consequences of balloon injury. Because injury of normal arteries is known to be significantly less thrombogenic than "second injury" of atherosclerotic arteries,23 the model studied in this investigation may be especially well suited to the investigation of antithrombotic therapies. The atherosclerotic lesions produced in this model were similar in morphological characteristics to those seen in human coronary arteries consisting primarily of fibrous tissue with few foam cells before angioplasty.31 Nevertheless, this study suggests that therapies found effective against intimal hyperplasia in one model (normal arteries) may be less effective in models with preexisting atherosclerotic plaque or in humans with coronary artery disease.
